|
| | Publication Year | Title | Author(s) |
| 1 | 13-Nov-2023 | Antibody drug conjugates for glioblastoma: current progress toward clinical use. | Gan, Hui K ; Parakh, Sagun ; Osellame, Laura D; Cher, Lawrence M ; Uccellini, Anthony; Hafeez, Umbreen ; Menon, Siddharth; Scott, Andrew M |
| 2 | 22-Aug-2022 | Correction to: Poor correlation between preclinical and patient efficacy data for tumor targeted monotherapies in glioblastoma: the results of a systematic review. | Gunjur, Ashray ; Balasubramanian, Adithya ; Hafeez, Umbreen ; Menon, Siddharth; Cher, Lawrence M ; Parakh, Sagun ; Gan, Hui K |
| 3 | 6-Aug-2022 | Poor correlation between preclinical and patient efficacy data for tumor targeted monotherapies in glioblastoma: the results of a systematic review. | Gunjur, Ashray ; Balasubramanian, Adithya ; Hafeez, Umbreen ; Menon, Siddharth; Cher, Lawrence M ; Parakh, Sagun ; Gan, Hui K |
| 4 | Aug-2022 | Adult medulloblastoma in an Australian population. | Parakh, Sagun ; Davies, Amy; Westcott, Kerryn; Roos, Daniel; Abou-Hamden, Amal; Ahern, Elizabeth; Lau, Peter K H; Cheruvu, Sowmya; Pranavan, Ganesalingam; Pullar, Andrew; Lynam, James; Gzell, Cecelia; Whittle, James R; Cain, Sarah; Inglis, Po-Ling; Harrup, Rosemary; Anazodo, Antoinette; Hovey, Elizabeth; Cher, Lawrence M ; Gan, Hui K |
| 5 | 3-Mar-2022 | The systemic management of central nervous system metastases and leptomeningeal disease from advanced lung, melanoma, and breast cancer with molecular drivers: An Australian perspective. | Senko, Clare ; Gunjur, Ashray ; Balasubramanian, Adithya ; Gan, Hui K ; Parakh, Sagun ; Cher, Lawrence M |
| 6 | 30-Dec-2021 | LUMOS - Low and Intermediate Grade Glioma Umbrella Study of Molecular Guided TherapieS at relapse: Protocol for a pilot study. | Kong, Benjamin Y; Sim, Hao-Wen; Nowak, Anna K; Yip, Sonia; Barnes, Elizabeth H; Day, Bryan W; Buckland, Michael E; Verhaak, Roel; Johns, Terrance; Robinson, Cleo; Thomas, Marc A; Giardina, Tindaro; Lwin, Zarnie; Scott, Andrew M ; Parkinson, Jonathon; Jeffree, Rosalind; Lourenco, Richard de Abreu; Hovey, Elizabeth J; Cher, Lawrence M ; Kichendasse, Ganessan; Khasraw, Mustafa; Hall, Merryn; Tu, Emily; Amanuel, Benhur; Koh, Eng-Siew; Gan, Hui K |
| 7 | 12-Nov-2021 | Outcomes from the use of computerized neurocognitive testing in a recurrent glioblastoma clinical trial. | Field, K M; Barnes, E H; Sim, H W; Nowak, A K; Simes, J; Rosenthal, M A; Wheeler, H; Hovey, E J; Cher, Lawrence M |
| 8 | Jan-2021 | Inefficiencies in phase II to phase III transition impeding successful drug development in glioblastoma. | Balasubramanian, Adithya ; Gunjur, Ashray ; Hafeez, Umbreen ; Menon, Siddharth; Cher, Lawrence M ; Parakh, Sagun ; Gan, Hui K |
| 9 | Sep-2020 | Response to combined BRAF/MEK inhibition in adult BRAF V600E mutant spinal pilocytic astrocytoma. | Balasubramanian, Adithya ; Gunjur, Ashray ; Gan, Hui Kong; Perchyonok, Yuliya ; Cher, Lawrence M |
| 10 | Jun-2020 | Spatial and quantitative mapping of glycolysis and hypoxia in glioblastoma as a predictor of radiotherapy response and sites of relapse. | Leimgruber, Antoine; Hickson, Kevin; Lee, Sze Ting ; Gan, Hui K ; Cher, Lawrence M ; Sachinidis, John I; O'Keefe, Graeme J; Scott, Andrew M |
Loading...
2
0
20
0
false